Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/30/24 → 1/30/27 |
Funding
- PPD Investigator Services, LLC (Prot #COVALENT-103 // Prot #COVALENT-103)
- Biomea Fusion Inc. (Prot #COVALENT-103 // Prot #COVALENT-103)
Prot #COVALENT-103: A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study of BMF-500, an Oral Covalent FLT3 Inhibitor, in Adults with Acute Leukemia
- Abaza, Yasmin (PD/PI)
Project: Research project